IART FY 2023 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.5B-1.0% YoY

Gross Profit

$885M57.4% margin

Operating Income

$112M7.2% margin

Net Income

$68M4.4% margin

EPS (Diluted)

$0.84

Cash Flow

Operating Cash Flow

$140M

Free Cash Flow

$73M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$2.2B

Stockholders' Equity

$1.6B

Cash & Equivalents

$276M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.6B	-1.0%
Gross Profit	$885M	$970M	-8.8%
Operating Income	$112M	$239M	-53.3%
Net Income	$68M	$181M	-62.5%